OpenAlex
PricingAboutJobs
Log inGet started
Work

Tropomyosin Receptor Kinase Inhibitors for the Treatment of TRK Fusion Cancer

HTML

Year: 2021
Type: review
Source: Clinical Cancer Research
DOI: 10.1158/1078-0432.ccr-21-0465
Authors: Theodore W. Laetsch, David S. Hong
Institutions: Children's Hospital of Philadelphia, Abramson Cancer Center, University of Pennsylvania, The University of Texas MD Anderson Cancer Center
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: NTRK gene fusions, TRK inhibitors, larotrectinib, entrectinib, small-molecule tyrosine kinase inhibitors, chromosomal rearrangements, multikinase inhibitor, drug resistance mechanisms, tumor detection, solid tumors
SDG: Good health and well-being

Open Access status: closed

Funder: Bayer
OpenAlex ID: W3152991128
FWCI: 1.763
Cites: 64
Cited by: 74
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security